Definium Therapeutics Announces New Employee Inducement Grants

Definium Therapeutics announced the issuance of inducement grants to five newly hired non-executive employees, consisting of options to purchase 255,340 common shares. The options will vest over a four-year period, with 25% vesting on the first anniversary of the grant date and the remaining 75% vesting in equal monthly increments over the following three years.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.